This study is a regulatory post marketing surveillance in Japan, and it is a local
prospective and observational study of patients who have received Wellnara for postmenopausal
osteoporosis. The objective of this study is to assess safety and efficacy of using Wellnara
in clinical practice. A total 400 patients will be recruited and followed 3 years since
starting Wellnara administration.